TCL Archive FY 1990 Bypass Budget f $2.345 Billion Approved By NCAB; Hammer’s Effort Makes That Possible May 20, 1988
TCL Archive ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic. April 9, 2010
TCL Archive Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review. November 14, 2003